Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Cardioprotection with halogenated gases: how does it occur?

Guerrero-Orriach JL, Escalona Belmonte JJ, Ramirez Fernandez A, Ramirez Aliaga M, Rubio Navarro M, Cruz Mañas J.

Drug Des Devel Ther. 2017 Mar 16;11:837-849. doi: 10.2147/DDDT.S127916. eCollection 2017. Review.

2.

Postconditioning of sevoflurane and propofol is associated with mitochondrial permeability transition pore.

He W, Zhang FJ, Wang SP, Chen G, Chen CC, Yan M.

J Zhejiang Univ Sci B. 2008 Feb;9(2):100-8. doi: 10.1631/jzus.B0710586.

3.
4.

Cardioprotection of sevoflurane postconditioning by activating extracellular signal-regulated kinase 1/2 in isolated rat hearts.

Chen HT, Yang CX, Li H, Zhang CJ, Wen XJ, Zhou J, Fan YL, Huang T, Zeng YM.

Acta Pharmacol Sin. 2008 Aug;29(8):931-41. doi: 10.1111/j.1745-7254.2008.00824.x.

5.

Induction of autophagy restores the loss of sevoflurane cardiac preconditioning seen with prolonged ischemic insult.

Shiomi M, Miyamae M, Takemura G, Kaneda K, Inamura Y, Onishi A, Koshinuma S, Momota Y, Minami T, Figueredo VM.

Eur J Pharmacol. 2014 Feb 5;724:58-66. doi: 10.1016/j.ejphar.2013.12.027. Epub 2013 Dec 25.

PMID:
24374197
6.

Upregulation of vascular endothelial growth factor receptor-1 contributes to sevoflurane preconditioning-mediated cardioprotection.

Qian B, Yang Y, Yao Y, Liao Y, Lin Y.

Drug Des Devel Ther. 2018 Apr 6;12:769-776. doi: 10.2147/DDDT.S162577. eCollection 2018.

7.

Hypercholesterolemic myocardium is vulnerable to ischemia-reperfusion injury and refractory to sevoflurane-induced protection.

Xu Y, Ma LL, Zhou C, Zhang FJ, Kong FJ, Wang WN, Qian LB, Wang CC, Liu XB, Yan M, Wang JA.

PLoS One. 2013 Oct 4;8(10):e76652. doi: 10.1371/journal.pone.0076652. eCollection 2013.

8.

The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo.

Obal D, Dettwiler S, Favoccia C, Scharbatke H, Preckel B, Schlack W.

Anesth Analg. 2005 Nov;101(5):1252-60.

PMID:
16243977
9.

Effects of sevoflurane preconditioning and postconditioning on rat myocardial stunning in ischemic reperfusion injury.

Dai AL, Fan LH, Zhang FJ, Yang MJ, Yu J, Wang JK, Fang T, Chen G, Yu LN, Yan M.

J Zhejiang Univ Sci B. 2010 Apr;11(4):267-74. doi: 10.1631/jzus.B0900390.

10.

Cardioprotective efficacy of sevoflurane vs. propofol during induction and/or maintenance in patients undergoing coronary artery revascularization surgery without pump: A randomized trial.

Guerrero Orriach JL, Galán Ortega M, Ramirez Fernandez A, Ramirez Aliaga M, Moreno Cortes MI, Ariza Villanueva D, Florez Vela A, Alcaide Torres J, Santiago Fernandez C, Matute Gonzalez E, Alsina Marcos E, Escalona Belmonte JJ, Rubio Navarro M, Garrido Sanchez L, Cruz Mañas J.

Int J Cardiol. 2017 Sep 15;243:73-80. doi: 10.1016/j.ijcard.2017.04.105. Epub 2017 May 3.

PMID:
28506550
11.

Cardioprotection via activation of protein kinase C-delta depends on modulation of the reverse mode of the Na+/Ca2+ exchanger.

Bouwman RA, Salic K, Padding FG, Eringa EC, van Beek-Harmsen BJ, Matsuda T, Baba A, Musters RJ, Paulus WJ, de Lange JJ, Boer C.

Circulation. 2006 Jul 4;114(1 Suppl):I226-32.

PMID:
16820577
12.

Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.

Ferdinandy P, Schulz R, Baxter GF.

Pharmacol Rev. 2007 Dec;59(4):418-58. Epub 2007 Nov 29. Review.

13.
14.

Sevoflurane enhances ethanol-induced cardiac preconditioning through modulation of protein kinase C, mitochondrial KATP channels, and nitric oxide synthase, in guinea pig hearts.

Kaneda K, Miyamae M, Sugioka S, Okusa C, Inamura Y, Domae N, Kotani J, Figueredo VM.

Anesth Analg. 2008 Jan;106(1):9-16, table of contents. doi: 10.1213/01.ane.0000297298.93627.36.

PMID:
18165545
15.

Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.

Onishi A, Miyamae M, Kaneda K, Kotani J, Figueredo VM.

Eur J Pharmacol. 2012 Jan 30;675(1-3):40-6. doi: 10.1016/j.ejphar.2011.11.040. Epub 2011 Dec 7.

PMID:
22166375
16.

Diabetes abolishes the cardioprotection induced by sevoflurane postconditioning in the rat heart in vivo: roles of glycogen synthase kinase-3β and its upstream pathways.

Tai W, Shi E, Yan L, Jiang X, Ma H, Ai C.

J Surg Res. 2012 Nov;178(1):96-104. doi: 10.1016/j.jss.2012.02.021. Epub 2012 Mar 30.

PMID:
22482760
17.

Gender-related difference of sevoflurane postconditioning in isolated rat hearts: focus on phosphatidylinositol-3-kinase/Akt signaling.

Zheng Z, Yang M, Zhang F, Yu J, Wang J, Ma L, Zhong Y, Qian L, Chen G, Yu L, Yan M.

J Surg Res. 2011 Sep;170(1):e3-9. doi: 10.1016/j.jss.2011.04.035. Epub 2011 May 17.

PMID:
21704330
18.

Prolonged sevoflurane administration in the off-pump coronary artery bypass graft surgery: beneficial effects.

Guerrero Orriach JL, Galán Ortega M, Ramirez Aliaga M, Iglesias P, Rubio Navarro M, Cruz Mañas J.

J Crit Care. 2013 Oct;28(5):879.e13-8. doi: 10.1016/j.jcrc.2013.06.004. Epub 2013 Jul 23.

PMID:
23886454
19.

Roles of cyclooxygenase 2 in sevoflurane- and olprinone-induced early phase of preconditioning and postconditioning against myocardial infarction in rat hearts.

Tosaka S, Tosaka R, Matsumoto S, Maekawa T, Cho S, Sumikawa K.

J Cardiovasc Pharmacol Ther. 2011 Mar;16(1):72-8. doi: 10.1177/1074248410380208. Epub 2010 Oct 11.

PMID:
20938040
20.

Comparison of cardioprotective effects of volatile anesthetics in children undergoing ventricular septal defect closure.

Singh P, Chauhan S, Jain G, Talwar S, Makhija N, Kiran U.

World J Pediatr Congenit Heart Surg. 2013 Jan;4(1):24-9. doi: 10.1177/2150135112457580.

PMID:
23799751

Supplemental Content

Support Center